De Rossi G, Mauro F R, Lo Coco F, Caruso R, Niscola P, Pasqualetti D, Mandelli F
Human Biopathology Department, University La Sapienza, Rome, Italy.
Nouv Rev Fr Hematol (1978). 1993 Aug;35(4):451-5.
We report 26 elderly patients (median age 68.3 years) who met diagnostic criteria for B-cell chronic lymphocytic leukaemia (B-CLL) but whose lymphocytes lacked CD5 expression. Haematological and clinical features of this CD5- series were compared with those of 333 CD5+ B-CLL patients from the same institute. No significant differences were observed regarding peripheral blood (PB) and bone marrow (BM) lymphocytosis, Hb level, platelet count, incidence of adenomegaly, hepatomegaly or splenomegaly or diffuse BM pattern. Due to an absence of nodal enlargements or to general clinical condition, lymph node biopsy was performed in only three patients, while spleen histology was examined in two cases following splenectomy. All histological results confirmed the clinical diagnosis of CLL. The distribution of the CD5- subjects according to the different staging categories proposed by Rai, Binet and Mandelli was similar to that of CD5+ subjects. Ten patients received standard chemotherapy with Chlorambucil (CHL) and Prednisone (PDN). All achieved partial remission, although one of these patients later died of disease progression; 80 months after diagnosis. We conclude that rare cases of CD5- lymphocytosis fulfilling all criteria for B-CLL may occur. Haematological and clinical features at presentation and the response to conventional treatment with Chlorambucil support our hypothesis of considering this disease as a less frequent subgroup of B-CLL.
我们报告了26例老年患者(中位年龄68.3岁),他们符合B细胞慢性淋巴细胞白血病(B-CLL)的诊断标准,但淋巴细胞缺乏CD5表达。将该CD5阴性系列患者的血液学和临床特征与来自同一机构的333例CD5阳性B-CLL患者进行了比较。在周围血(PB)和骨髓(BM)淋巴细胞增多、血红蛋白水平、血小板计数、淋巴结肿大、肝肿大或脾肿大的发生率或弥漫性BM模式方面未观察到显著差异。由于没有淋巴结肿大或考虑到一般临床情况,仅3例患者进行了淋巴结活检,2例患者在脾切除术后检查了脾脏组织学。所有组织学结果均证实了CLL的临床诊断。根据Rai、Binet和Mandelli提出的不同分期类别,CD5阴性患者的分布与CD5阳性患者相似。10例患者接受了苯丁酸氮芥(CHL)和泼尼松(PDN)的标准化疗。所有患者均达到部分缓解,尽管其中1例患者后来死于疾病进展,诊断后80个月。我们得出结论,可能会出现符合B-CLL所有标准的罕见CD5阴性淋巴细胞增多病例。就诊时的血液学和临床特征以及对苯丁酸氮芥常规治疗的反应支持我们将这种疾病视为B-CLL较不常见亚组的假设。